September 06, 2021
Weil is advising Advent International Corporation and Agnafit Bidco on the $8 billion recommended cash offer for listed Swedish biopharma company, Swedish Orphan Biovitrum AB (Sobi). This is the largest buyout in Sweden to date, and the largest Nordic buyout in more than five years. Weil is advising alongside Roschier who are providing Swedish law advice.
The Weil team is being led by Private Equity partner Jonathan Wood, supported by M&A partner Murray Cox and Private Equity partner Max Oppenheimer, and Banking partner Tom Richards and High Yield partner Nitin Konchady. The team includes: Private Equity partner Lewis Blakey and associates Martin Weatherston-Wilson, Jamie Macdonagh, Michael Grant, Grace Smith, and Henrietta Wirta; High Yield partner Patrick Bright; Banking associates Patrick Brendon, Conor Campbell, Kai Zhang, Jessica Carty and Abdul Wahaab Din; Antitrust/Competition partner Jenine Hulsmann, Counsel Neil Rigby and Nafees Saeed, and associates Christopher Thomas and Alison Finneran; Technology and IP partner Jeffrey Osterman and associate Kane Wishart; and Patent Litigation partner Elizabeth Weiswasser.